- Home
- JANX vs USA Comparison
JANX vs USA Comparison
Compare JANX & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- USA
- Stock Information
- Founded
- JANX 2017
- USA 1986
- Country
- JANX United States
- USA United States
- Employees
- JANX N/A
- USA N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- USA Finance Companies
- Sector
- JANX Health Care
- USA Finance
- Exchange
- JANX Nasdaq
- USA Nasdaq
- Market Cap
- JANX 1.6B
- USA N/A
- IPO Year
- JANX 2021
- USA N/A
- Fundamental
- Price
- JANX $26.37
- USA $6.52
- Analyst Decision
- JANX Strong Buy
- USA
- Analyst Count
- JANX 7
- USA 0
- Target Price
- JANX $94.29
- USA N/A
- AVG Volume (30 Days)
- JANX 974.6K
- USA 880.5K
- Earning Date
- JANX 05-20-2025
- USA 01-01-0001
- Dividend Yield
- JANX N/A
- USA 9.66%
- EPS Growth
- JANX N/A
- USA N/A
- EPS
- JANX N/A
- USA N/A
- Revenue
- JANX $10,588,000.00
- USA N/A
- Revenue This Year
- JANX N/A
- USA N/A
- Revenue Next Year
- JANX $250.58
- USA N/A
- P/E Ratio
- JANX N/A
- USA N/A
- Revenue Growth
- JANX 30.99
- USA N/A
- 52 Week Low
- JANX $22.52
- USA $5.62
- 52 Week High
- JANX $71.71
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- JANX 39.10
- USA 57.34
- Support Level
- JANX $31.34
- USA $6.40
- Resistance Level
- JANX $33.97
- USA $6.28
- Average True Range (ATR)
- JANX 1.94
- USA 0.11
- MACD
- JANX -0.52
- USA 0.05
- Stochastic Oscillator
- JANX 22.76
- USA 97.10
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.